In Vitro Assessment of Antiborrelial Activity of OspA Vaccine Sera-Reference-Cited by-同舟云学术

In Vitro Assessment of Antiborrelial Activity of OspA Vaccine Sera

Published:2002-07 Issue:4 Volume:9 Page:919-920
ISSN:1556-6811
Container-title:Clinical and Vaccine Immunology
language:en
Short-container-title:Clin Vaccine Immunol

Author:

Fawcett Paul T.¹²,Rose Carlos D.³²,Gibney Kathleen M.¹

Affiliation:

1. Immunology Laboratory, Department of Research

2. Department of Pediatrics, Thomas Jefferson University, Philadelphia, Pennsylvania

3. Division of Rheumatology, Department of Pediatrics, A. I. duPont Hospital for Children, Wilmington, Delaware

Abstract

ABSTRACT Prevention of Lyme disease by the recombinant OspA-based vaccine reportedly works by preventing transmission of spirochetes from ticks to humans. We report on an in vitro microculture assay, which can be used to provide an indicator of the need for booster doses of vaccine.

Publisher

American Society for Microbiology

Subject

Microbiology (medical),Clinical Biochemistry,Immunology,Immunology and Allergy

Link

https://journals.asm.org/doi/pdf/10.1128/CDLI.9.4.919-920.2002

Reference14 articles.

1. Callister, S. M., R. F. Schell, L. C. L. Lim, D. A. Jobe, K. L. Case, G. L. Bryant, and P. E. Molling. 1994. Detection of borreliacidal antibodies by flow cytometry. Arch. Intern. Med.154:1625-1632.

2. Selection of an escape variant of Borrelia burgdorferi by use of bactericidal monoclonal antibodies to OspB

3. Fawcett, P. T., C. D. Rose, and K. M. Gibney. 1995. Comparative evaluation of adsorption with E. coli on ELISA tests for Lyme borreliosis. J. Rheumatol.22:684-688.

4. Effect of Immunization with Recombinant OspA on Serologic Tests for Lyme Borreliosis

5. Fawcett, P. T., K. M. Gibney, C. D. Rose, S. B. Dubbs, and R. A. Doughty. 1998. Frequency and specificity of antibodies that cross-react with Borrelia burgdorferi antigens. J. Rheumatol.19:582-587.